{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T06:46:49Z","timestamp":1769237209971,"version":"3.49.0"},"reference-count":55,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","arthroplastyjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Arthroplasty"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1016\/j.arth.2017.07.006","type":"journal-article","created":{"date-parts":[[2017,7,14]],"date-time":"2017-07-14T23:30:41Z","timestamp":1500075041000},"page":"3669-3674","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Does Multiple Sclerosis Affect the Inpatient Perioperative Outcomes After Total Hip Arthroplasty?"],"prefix":"10.1016","volume":"32","author":[{"given":"Jared M.","family":"Newman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qais","family":"Naziri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Morad","family":"Chughtai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anton","family":"Khlopas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas J.","family":"Kryzak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suparna M.","family":"Navale","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos A.","family":"Higuera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael A.","family":"Mont","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.arth.2017.07.006_bib1","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1016\/S0140-6736(08)61620-7","article-title":"Multiple sclerosis","volume":"372","author":"Compston","year":"2008","journal-title":"Lancet (London, England)"},{"issue":"2 Suppl","key":"10.1016\/j.arth.2017.07.006_bib2","first-page":"S15","article-title":"Overview of the epidemiology, diagnosis, and disease progression associated with multiple sclerosis","volume":"19","author":"Tullman","year":"2013","journal-title":"Am J Manag Care"},{"key":"10.1016\/j.arth.2017.07.006_bib3","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/S1474-4422(04)00933-0","article-title":"Environmental risk factors in multiple sclerosis aetiology","volume":"3","author":"Marrie","year":"2004","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.arth.2017.07.006_bib4","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1212\/WNL.0000000000002469","article-title":"Multiple sclerosis prevalence in the United States commercially insured population","volume":"86","author":"Dilokthornsakul","year":"2016","journal-title":"Neurology"},{"issue":"Suppl 5","key":"10.1016\/j.arth.2017.07.006_bib5","first-page":"S139","article-title":"Improving quality of life in multiple sclerosis: an unmet need","volume":"17","author":"Zwibel","year":"2011","journal-title":"Am J Manag Care"},{"key":"10.1016\/j.arth.2017.07.006_bib6","doi-asserted-by":"crossref","first-page":"6","DOI":"10.7224\/1537-2073-11.1.6","article-title":"Comorbidity and health-related quality of life in people with multiple sclerosis","volume":"11","author":"Warren","year":"2009","journal-title":"Int J MS Care"},{"key":"10.1016\/j.arth.2017.07.006_bib7","first-page":"1046","article-title":"General health issues in multiple sclerosis: comorbidities, secondary conditions, and health behaviors","volume":"19","author":"Marrie","year":"2013","journal-title":"Continuum (Minneap Minn)"},{"key":"10.1016\/j.arth.2017.07.006_bib8","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1007\/s10072-011-0914-8","article-title":"Avascular necrosis of the femoral head in multiple sclerosis: report of five patients","volume":"33","author":"Sahraian","year":"2012","journal-title":"Neurol Sci"},{"key":"10.1016\/j.arth.2017.07.006_bib9","first-page":"257","article-title":"A\u00a0steroid-induced bilateral avascular necrosis of the femoral head in an underage patient affected by multiple sclerosis","volume":"12","author":"Carulli","year":"2015","journal-title":"Clin Cases Miner Bone Metab"},{"key":"10.1016\/j.arth.2017.07.006_bib10","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1111\/j.1468-1331.2006.01375.x","article-title":"Avascular necrosis of the bones: an overlooked complication of pulse steroid treatment of multiple sclerosis","volume":"13","author":"Ce","year":"2006","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.arth.2017.07.006_bib11","doi-asserted-by":"crossref","first-page":"780","DOI":"10.2106\/00004623-200704000-00012","article-title":"Projections of primary and revision hip and knee arthroplasty in the United States from 2005 to 2030","volume":"89","author":"Kurtz","year":"2007","journal-title":"J\u00a0Bone Joint Surg Am"},{"key":"10.1016\/j.arth.2017.07.006_bib12","series-title":"Multiple sclerosis: diagnosis and therapy","first-page":"163","article-title":"Predicting clinical course","author":"Healy","year":"2012"},{"key":"10.1016\/j.arth.2017.07.006_bib13","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1212\/WNL.46.4.907","article-title":"Defining the clinical course of multiple sclerosis: results of an international survey. National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis","volume":"46","author":"Lublin","year":"1996","journal-title":"Neurology"},{"key":"10.1016\/j.arth.2017.07.006_bib14","series-title":"Multiple sclerosis: diagnosis and therapy","first-page":"213","article-title":"Symptom management","author":"Stazzone","year":"2012"},{"key":"10.1016\/j.arth.2017.07.006_bib15","first-page":"26","article-title":"Orthopaedic management of spasticity","volume":"98","author":"Pidgeon","year":"2015","journal-title":"R\u00a0Med J (2013)"},{"key":"10.1016\/j.arth.2017.07.006_bib16","series-title":"Controlling spasticity in MS","author":"Holland","year":"2016"},{"issue":"Suppl 5","key":"10.1016\/j.arth.2017.07.006_bib17","first-page":"S146","article-title":"Functional improvement and symptom management in multiple sclerosis: clinical efficacy of current therapies","volume":"17","author":"Berger","year":"2011","journal-title":"Am J Manag Care"},{"issue":"Suppl","key":"10.1016\/j.arth.2017.07.006_bib18","first-page":"20","article-title":"Botulinum toxin treatment of hip adductor spasticity in multiple sclerosis","volume":"113","author":"Wissel","year":"2001","journal-title":"Wien Klin Wochenschr"},{"key":"10.1016\/j.arth.2017.07.006_bib19","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1302\/0301-620X.91B10.22934","article-title":"Total hip replacement in patients with neurological conditions","volume":"91-B","author":"Queally","year":"2009","journal-title":"J\u00a0Bone Joint Surg Br"},{"key":"10.1016\/j.arth.2017.07.006_bib20","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1007\/s11999-011-2139-9","article-title":"Is the dislocation rate higher after bipolar hemiarthroplasty in patients with neuromuscular diseases?","volume":"470","author":"Suh","year":"2012","journal-title":"Clin Orthop Relat Res"},{"key":"10.1016\/j.arth.2017.07.006_bib21","first-page":"163","article-title":"Total hip arthroplasty in patients with neuromuscular disease","volume":"49","author":"Cabanela","year":"2000","journal-title":"Instr Course Lect"},{"key":"10.1016\/j.arth.2017.07.006_bib22","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1136\/jnnp.68.6.707","article-title":"Botulinum toxin (Dysport) treatment of hip adductor spasticity in multiple sclerosis: a prospective, randomised, double blind, placebo controlled, dose ranging study","volume":"68","author":"Hyman","year":"2000","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.arth.2017.07.006_bib23","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1002\/ana.410280407","article-title":"Treatment of spasticity with botulinum toxin: a double-blind study","volume":"28","author":"Snow","year":"1990","journal-title":"Ann Neurol"},{"key":"10.1016\/j.arth.2017.07.006_bib24","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1080\/10790268.2005.11754545","article-title":"Spasticity management in multiple sclerosis evidence-based management strategies for spasticity treatment in multiple sclerosis","volume":"28","author":"Haselkorn","year":"2005","journal-title":"J\u00a0Spinal Cord Med"},{"key":"10.1016\/j.arth.2017.07.006_bib25","doi-asserted-by":"crossref","first-page":"8","DOI":"10.7224\/1537-2073-3.4.8","article-title":"Management of spasticity in multiple sclerosis","volume":"3","author":"Herndon","year":"2001","journal-title":"Int J MS Care"},{"key":"10.1016\/j.arth.2017.07.006_bib26","series-title":"Healthcare Cost and Utilization Project (HCUP)","author":"HCUP Nationwide Inpatient Sample (NIS)","year":"2013"},{"key":"10.1016\/j.arth.2017.07.006_bib27","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1001\/jamaneurol.2013.5993","article-title":"Vitamin D as an early predictor of multiple sclerosis activity and progression","volume":"71","author":"Ascherio","year":"2014","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.arth.2017.07.006_bib28","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1007\/s11999-014-3855-8","article-title":"Does HIV infection increase the risk of perioperative complications after THA? A nationwide database study","volume":"473","author":"Naziri","year":"2015","journal-title":"Clin Orthop Relat Res"},{"key":"10.1016\/j.arth.2017.07.006_bib29","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1016\/j.arth.2016.04.011","article-title":"Impact of cirrhosis on resource use and inpatient complications in patients undergoing total knee and hip arthroplasty","volume":"31","author":"Newman","year":"2016","journal-title":"J\u00a0Arthroplasty"},{"key":"10.1016\/j.arth.2017.07.006_bib30","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1016\/j.arth.2014.06.018","article-title":"Primary total knee arthroplasty allogenic transfusion trends, length of stay, and complications: nationwide inpatient sample 2000-2009","volume":"29","author":"Klika","year":"2014","journal-title":"J\u00a0Arthroplasty"},{"key":"10.1016\/j.arth.2017.07.006_bib31","series-title":"Healthcare Cost and Utilization Project (HCUP). Agency for Healthcare Research and Quality. 2002-2013","author":"HCUP Comorbidity Software","year":"2014"},{"key":"10.1016\/j.arth.2017.07.006_bib32","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1097\/00005650-199801000-00004","article-title":"Comorbidity measures for use with administrative data","volume":"36","author":"Elixhauser","year":"1998","journal-title":"Med Care"},{"key":"10.1016\/j.arth.2017.07.006_bib33","series-title":"Regression Methods in Biostatistics Linear, Logistic, Survival, and Repeated Measures Models","first-page":"69","article-title":"Linear regression","author":"Vittinghoff","year":"2012"},{"key":"10.1016\/j.arth.2017.07.006_bib34","first-page":"175","article-title":"Multiple sclerosis review","volume":"37","author":"Goldenberg","year":"2012","journal-title":"P\u00a0T"},{"key":"10.1016\/j.arth.2017.07.006_bib35","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.neurol.2015.10.006","article-title":"Epidemiology of multiple sclerosis","volume":"172","author":"Leray","year":"2016","journal-title":"Rev Neurol (Paris)"},{"issue":"11 Suppl 5","key":"10.1016\/j.arth.2017.07.006_bib36","doi-asserted-by":"crossref","first-page":"S12","DOI":"10.1212\/WNL.63.11_suppl_5.S12","article-title":"A\u00a0multimodal approach to managing the symptoms of multiple sclerosis","volume":"63","author":"Crayton","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.arth.2017.07.006_bib37","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.2106\/JBJS.O.00071","article-title":"Nontraumatic osteonecrosis of the femoral head: where do we stand today? A ten-year update","volume":"97","author":"Mont","year":"2015","journal-title":"J\u00a0Bone Joint Surg Am"},{"key":"10.1016\/j.arth.2017.07.006_bib38","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1016\/j.arth.2015.03.036","article-title":"High-dose corticosteroid use and risk of hip osteonecrosis: meta-analysis and systematic literature review","volume":"30","author":"Mont","year":"2015","journal-title":"J\u00a0Arthroplasty"},{"key":"10.1016\/j.arth.2017.07.006_bib39","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1007\/s11910-011-0214-y","article-title":"Gait abnormalities in multiple sclerosis: pathogenesis, evaluation, and advances in treatment","volume":"11","author":"Cameron","year":"2011","journal-title":"Curr Neurol Neurosci Rep"},{"key":"10.1016\/j.arth.2017.07.006_bib40","first-page":"1007","article-title":"Gait disorders in multiple sclerosis","volume":"19","author":"Bethoux","year":"2013","journal-title":"Continuum (Minneap Minn)"},{"key":"10.1016\/j.arth.2017.07.006_bib41","doi-asserted-by":"crossref","first-page":"189","DOI":"10.2165\/11591150-000000000-00000","article-title":"Impact of walking impairment in multiple sclerosis: perspectives of patients and care partners","volume":"4","author":"Larocca","year":"2011","journal-title":"Patient"},{"key":"10.1016\/j.arth.2017.07.006_bib42","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.gaitpost.2008.07.011","article-title":"Gait analysis in multiple sclerosis: characterization of temporal-spatial parameters using GAITRite functional ambulation system","volume":"29","author":"Givon","year":"2009","journal-title":"Gait Posture"},{"key":"10.1016\/j.arth.2017.07.006_bib43","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1177\/1352458509102844","article-title":"Vitamin D status and effect of low-dose cholecalciferol and high-dose ergocalciferol supplementation in multiple sclerosis","volume":"15","author":"Hiremath","year":"2009","journal-title":"Mult Scler"},{"key":"10.1016\/j.arth.2017.07.006_bib44","first-page":"493","article-title":"Surgery of the extremities in patients with multiple sclerosis","volume":"51","author":"Glazer","year":"1970","journal-title":"Arch Phys Med Rehabil"},{"key":"10.1016\/j.arth.2017.07.006_bib45","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1212\/WNL.53.8.1622","article-title":"Multiple sclerosis: side effects of interferon beta therapy and their management","volume":"53","author":"Walther","year":"1999","journal-title":"Neurology"},{"key":"10.1016\/j.arth.2017.07.006_bib46","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1007\/s10072-015-2348-1","article-title":"Interferon-\u03b2 therapy and risk of thrombocytopenia in multiple sclerosis patients","volume":"36","author":"Koudriavtseva","year":"2015","journal-title":"Neurol Sci"},{"key":"10.1016\/j.arth.2017.07.006_bib47","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1016\/j.arth.2014.05.015","article-title":"Morbidity and mortality in the thirty-day period following total hip arthroplasty: risk factors and incidence","volume":"29","author":"Belmont","year":"2014","journal-title":"J\u00a0Arthroplasty"},{"key":"10.1016\/j.arth.2017.07.006_bib48","first-page":"743","article-title":"Multiple sclerosis and the urologist","volume":"161","author":"Litwiller","year":"1999","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.arth.2017.07.006_bib49","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/0090-4295(92)90045-X","article-title":"Lower urinary tract dysfunction in multiple sclerosis","volume":"39","author":"Mayo","year":"1992","journal-title":"Urology"},{"key":"10.1016\/j.arth.2017.07.006_bib50","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1177\/1352458506075651","article-title":"The neurogenic bladder in multiple sclerosis: review of the literature and proposal of management guidelines","volume":"13","author":"de S\u00e8ze","year":"2007","journal-title":"Mult Scler"},{"key":"10.1016\/j.arth.2017.07.006_bib51","doi-asserted-by":"crossref","first-page":"179","DOI":"10.7224\/1537-2073-14.4.179","article-title":"Self-reported burden among caregivers of patients with multiple sclerosis","volume":"14","author":"Gupta","year":"2012","journal-title":"Int J MS Care"},{"key":"10.1016\/j.arth.2017.07.006_bib52","first-page":"105","article-title":"Resurfacing hip arthroplasty in neuromuscular hip disorders \u2013 a retrospective case series","volume":"10","author":"Tudor","year":"2013","journal-title":"J\u00a0Orthop"},{"key":"10.1016\/j.arth.2017.07.006_bib53","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1016\/j.arth.2014.03.005","article-title":"Outcomes of total hip arthroplasty in spastic patients","volume":"29","author":"Alosh","year":"2014","journal-title":"J\u00a0Arthroplasty"},{"key":"10.1016\/j.arth.2017.07.006_bib54","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1007\/s00402-013-1759-9","article-title":"The use of a dual-mobility concept in total hip arthroplasty patients with spastic disorders: no dislocations in a series of ten cases at midterm follow-up","volume":"133","author":"Sanders","year":"2013","journal-title":"Arch Orthop Trauma Surg"},{"key":"10.1016\/j.arth.2017.07.006_bib55","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1097\/00003086-200403000-00017","article-title":"The role of constrained liners in total hip arthroplasty","author":"Su","year":"2004","journal-title":"Clin Orthop Relat Res"}],"container-title":["The Journal of Arthroplasty"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0883540317305892?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0883540317305892?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,10,12]],"date-time":"2020-10-12T12:41:20Z","timestamp":1602506480000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0883540317305892"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":55,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["S0883540317305892"],"URL":"https:\/\/doi.org\/10.1016\/j.arth.2017.07.006","relation":{},"ISSN":["0883-5403"],"issn-type":[{"value":"0883-5403","type":"print"}],"subject":[],"published":{"date-parts":[[2017,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Does Multiple Sclerosis Affect the Inpatient Perioperative Outcomes After Total Hip Arthroplasty?","name":"articletitle","label":"Article Title"},{"value":"The Journal of Arthroplasty","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.arth.2017.07.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}